EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis

Status unconfirmed · Not applicable

Conditions studied: Neurologic Disorder, Paralysis, Paralysis; Stroke, Amyotrophic Lateral Sclerosis, Spinal Cord Injuries, Cervical Spinal Cord Injury, Tetraplegic; Paralysis, Quadriplegia/Tetraplegia

In brief

Neuralis is an innovative assistive technology designed for individuals with severe neuromuscular conditions, enabling wheelchair control through EEG signals. This study aims to assess the safety, feasibility, and efficacy of Neuralis in restoring mobility and independence. The device is a discreet EEG headset which specializes in decoding signals from visual cortex, allowing users to initiate precise wheelchair movements through focused attention. This research seeks to demonstrate Neuralis' potential in revolutionizing assistive technology by offering a non-invasive, user-friendly solution for individuals facing motor impairments, ultimately enhancing their quality of life.

Key facts

Study ID

NCT06169696

Run by

Synaptrix Labs Inc.

People needed

6

Starts

2024-11-01

Expected to finish

2025-01-01

Last updated by the study team

2024-01-18

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Severe quadriparesis
• Able to give consent
• Appropriate candidate for device
• Able and willing to access all clinical testing and not impeded by geographical location
• Proficient in English
• Have a study partner

You may not qualify if…

• History of seizures
• History of epilepsy
• Psychiatric or psychological disorder
• No study partner or caregiver
• Unable to provide evidence of COVID vaccination

Where it is running

• Synaptrix Labs — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.